John V. Balen, Director at Cardlytics, Inc. (CDLX), bought 5,000 shares at $27.56 ($137K) on 2022-05-27, disclosed to the SEC on 2022-05-31.
Open-market purchase of $137k CDLX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.18 | 1,000 | $27K | 19.8% |
| 2 | $27.31 | 1,000 | $27K | 19.9% |
| 3 | $27.39 | 1,000 | $27K | 20.0% |
| 4 | $27.56 | 2,000 | $55K | 40.2% |
| Total | $27.40 avg | 5,000 | $137K | 100% |
| Filing → |
| CDLX | BUY | 2022-05-10 | $88K | — | Filing → |
| CDLX | BUY | 2021-08-31 | $90K | — | Filing → |
| CDLX | BUY | 2021-08-23 | $160K | — | Filing → |